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Abstract
Tinnitus has often been studied using salicylate in animal models as they are capable of inducing tempo-
rary hearing loss and tinnitus. Studies have recently observed enhancement of auditory evoked responses of
the auditory cortex (AC) post salicylate treatment which is also shown to be related to tinnitus like behavior
in rats. The aim of this study was to observe if enhancements of the AC post salicylate treatment are also
present at structures in the brainstem. Four male Sprague Dawley rats with AC implanted electrodes were
tested for both AC and auditory brainstem response (ABR) recordings pre and post 250 mg/kg intraperitone-
al injections of salicylate. The responses were recorded as the peak to trough amplitudes of P1-N1 (AC),
ABR wave V, and ABR wave Ⅱ. AC responses resulted in statistically significant enhancement of ampli-
tude at 2 hours post salicylate with 90 dB stimuli tone bursts of 4, 8, 12, and 20 kHz. Wave V of ABR re-
sponses at 90 dB resulted in a statistically significant reduction of amplitude 2 hours post salicylate and a
mean decrease of amplitude of 31% for 16 kHz. WaveⅡ amplitudes at 2 hours post treatment were signifi-
cantly reduced for 4, 12, and 20 kHz stimuli at 90 dB SPL. Our results suggest that the enhancement chang-
es of the AC related to salicylate induced tinnitus are generated superior to the level of the inferior colliculus
and may originate in the AC.
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Introduction
Subjective tinnitus is the sensation of sound in the ab-
sence of an acoustic stimulus. Research suggests that tin-
nitus affects between 15-19% of the population [1-3] and
can be induced by noise exposure [4,5] or ototoxic drugs [6,7]
(Huang & Schacht, 1989; Day et al., 1989) and is usually
associated with a cochlear damage [3,5].Salicylate has long
been known for inducing temporary hearing loss and tin-
nitus in humans [8,9]. Observations of tinnitus-like behav-
iors suggest that animals also experience tinnitus with
treatment of salicylate [10-13].Consequently,salicylates have
often been used in research to study the neurophysiolog-
ic mechanisms of tinnitus.Although tinnitus is most com-
monly associated with cochlear damage, there is evi-
dence that it may originate in the central nervous system.
The following background will discuss previous observa-
tions regarding tinnitus and the questions they provoke
regarding the structure of origin.
Yang et al. (2007) has shown enhancement of auditory
evoked cortical electrophysiological response to high in-
tensity tone burst stimuli in awake rats after administer-
ing 150 mg/kg of salicylate.They measured the P1-N1
amplitude, presumably the response from the auditory
cortex (AC), pre-salicylate treatment.The measurement
was repeated again at 2 hours, 1, 2 and 3 days post treat-
ment. Yang et al. observed the cortical enhancement was
most prominent in response to 16 and 20 kHz tone bursts 2
hours post salicylate treatment.These frequencies and time
intervals closely correlated to tinnitus-like behavior in an-
other group of rats treated similarly with salicylate [13]. The
authors suggested that the amplitude enhancement of
P1-N1observed with super threshold tone bursts in rats
treated with salicylate may be associated with tinnitus
and hyperacusis.
Several studies have observed a similar auditory evok-
30
2014 Vol.9 No.1
ed electrophysiological enhancement lower in the brain-
stem post noise exposure.Salvi et al. (2000) reviewed
changes of auditory evoked potentials in chinchillas
from the cochlea, the cochlear nucleus, and the inferior
colliculus (IC) pre and post noise exposure or carboplat-
in treatment [14]. Post noise exposure, poorer thresholds
were observed for soft auditory stimuli at all three struc-
tures, but enhancement of amplitude with high intensity
stimuli was observed at the level of the IC and AC [14].
As the auditory enhancement was not seen at the cochlea
or cochlear nucleus, they concluded that this enhance-
ment originated at or just before the IC. Liu et al.,
(2003) observed increases in extracellular levels of daily-
sate glucose and lactate in both the AC and the IC after
administration of salicylate [15].Basta and Ernst (2004)
found an overall increase in spontaneous firing rates in
mouse IC brain slices post salicylate superfusion [16].
Bauer et al. (2000) observed altered GABA(A) receptor
binding and GAD expression with chronic exposure to
salicylate in the IC of rats [17]. Taken together, these stud-
ies all suggest that neurophysiologic changes related to
tinnitus occur at the level of the IC.
Kaltenbach and associates (2002) evaluated the rela-
tionship between near field recordings of spontaneous
discharge rates from the dorsal cochlear nucleus and the
number of missing inner and outer hair cell loss post cis-
platin-induced cochlear damage in hamsters [18]. They ob-
served hyperactivity in spontaneous discharge rate in the
dorsal cochlear nucleus when the cochlea sustained sig-
nificantly more outer hair cell damage than inner hair
cell damage [18]. It was suggested that hyperactivity in the
dorsal cochlear nucleus may be a cause of tinnitus. It
may be reasonable to consider that Salvi et al. did not ob-
serve this change at the level of the dorsal cochlear nucle-
us due to electrode placement at the IC or because of dif-
ferences in neurological changes with noise exposure or
carboplatin induced hearing loss compared to Kalten-
bach’s use of cisplatin.
Prior to these studies, it has been shown that salicylate
in guinea pigs causes reduced amplitude of the compound
action potential of the cochlea and eighth cranial nerve
for low intensity stimuli, but no change with higher inten-
sity stimuli [19].Another study that suggests that the co-
chlea is not the place of origin of changes related to tinni-
tus was performed by Müller et al. [20]. They used local
electrodes placed near the round window to record the
compound action potential, and micropipettes inserted in-
to the cochlear nerve to record spontaneous activity in
anesthetized gerbils. After systemic application of salic-
ylate, the compound action potential thresholds were ele-
vated, single fiber thresholds were elevated, and sponta-
neous discharge rates were significantly reduced [20].
They asserted that changes associated with increased ac-
tivity in the central auditory system post salicylate are
not likely caused by hyperactivity of the cochlear nerve.
Collectively, these results suggest that hearing loss oc-
curs at the periphery and changes of increased spontane-
ous discharge rates, metabolic changes, and enhanced re-
sponse to high intensity stimuli originate in the cochlear
nucleus, IC, or AC.These changes are hypothesized to be
related to the perception of tinnitus. The purpose of this
study is to observe if the auditory evoked potential super
threshold enhancement previously observed at the corti-
cal level post salicylate treatment in rats will also be
present in the brainstem evoked waveform.Previous stud-
ies using noise exposure, carboplatin or cisplatin suggest
that enhancement may be observed at the level of the IC
and the cochlear nucleus.
Previous studies suggest that salicylate causes an am-
plitude enhancement of the auditory evoked potential
waveform of the AC.It is not clear if the enhancement
originates in the AC, the IC, or lower levels of the audito-
ry pathway. To address this question, we recorded AC
and brainstem evoked potential waveforms from four im-
planted animals both pre and post salicylate.The brain-
stem waveform was analyzed at specific latencies to at-
tempt to recognize the source of these changes.
Experimental procedures
Experimental animals and restraint procedures:
Four male Sprague Dawley rats, implanted approximate-
ly 2-3 months old, were tested for auditory cortical and
brainstem evoked electrophysiological testing at approxi-
mately 6-7 months of age. The implant consists of two
implanted electrodes and a threaded holding bar for head
restraint, all fixed in place to the surface of the skull
with stainless steel screws and dental cement. One of
the electrodes was made from A-M Systems Inc. silver
Teflon wire (.008 inches) melted into a ball-end elec-
trode placed on the right AC. The second electrode was
made from tungsten Teflon wire (.008 inches) and af-
fixed to the surface of the skull to serve as the reference.
The AC electrode position was identified from the su-
ture on the skull and the blood vessel on the surface of
the cortex.The implant procedure has been previously de-
scribed in detail [13].During testing, the animals were re-
strained inside a modified rat restrainer (Braintree Scien-
tific, G-4) to provide unrestricted acoustic access to both
ears. Moderately firm head restraint was used that re-
stricts head movement to small twisting motions by fix-
ing a bar to the implanted threaded holding bar that was
held with a World Precision Instruments M11 holding de-
vice. The animal was trained to the procedure until it
could remain relaxed throughout the restraint process.
This procedure has been extensively used within our
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labs and was approved by the Institutional Animal Care
and Use Committee at the University at Buffalo, the
State University of New York.
Sound stimuli: The stimuli used were 4 ms alternat-
ing polarity tone bursts of 4, 8, 12, 16 and 20 kHz de-
signed in Tucker Davis Technologies (TDT) SigGen RP
4.4 software. The stimuli were generated and processed
using TDT RX6 processor,TDT PA5 attenuator, and
TDT HB7 headphone driver. The sound was transduced
with a Fostex Corporation FT28D 8 ohm tweeter placed
approximately 2 ¼ inches from the animal’s left ear for
AC recording (contralateral to the AC electrode) and
right ear for ABR recording (ipsilateral to the AC elec-
trode). The stimuli was calibrated by modifying the Sig-
Gen file stimuli to be continuous and analyzing the lev-
els using a ½ inch Larson Davis (LD) model 2540 micro-
phone coupled to a LD System 824 sound level meter.
Recording hardware: The recording hardware con-
sisted of a TDT RA4LI four channel low impedance
head stage connected to RA16 PA 16 Channel Medusa
Preamp. The electrode montage used for AC recording
was negative terminal of the head stage RA4LI to the
AC-placed ball-end electrode while the common and
channel 1 were both affixed to the skull-placed electrode
(recording electrode contralateral to stimuli).For ABR re-
cording, the connections were switched to channel 1 con-
nected to the skull electrode, and the negative and com-
mon connected to the AC (recording electrode ipsilateral
to stimuli). The RA17PA was wired to an RA16 Medusa
Base Station for recording.
AC recording: The data was collected using TDT Bi-
oSig RP 4.41 software supported by Windows XP profes-
sional. BioSig settings for AC recording utilized a high
pass filter of 3 Hz, a low pass filter of 1000 Hz, and a
notch filter to remove 60 Hz.Stimulation rate for AC was
2/second and averaged 100 sweeps for each waveform.
Stimuli was presented and recorded in a descending
scale of 10 dB increments beginning at 100 or 90 dB as
the stimuli allowed. Repeats were performed with any
waveforms not consistent with a clear progression of re-
duction in amplitude and increase in latency as stimuli in-
tensity decreased.The schedule was modified when near
threshold to a 5 dB reduction schedule and repeats were
performed as necessary to provide confident threshold es-
timation. Recording for each stimulus intensity level for
AC recording was 100 averages with a gain of 20 dB.
Recording duration was 300 ms with no onset delay.
Two to four baselines, depending on stability and consis-
tency of observed data, were recorded and averaged for
later comparison to post salicylate recordings. The data
was recorded as middle latency recording peak to peak
P1 to N1 amplitude as a function of stimulus intensity
and saved in Microsoft Excel for later statistical analy-
sis.
ABR recording: The data for auditory brainstem re-
sponse (ABR) was recorded with the same software set
up as AC recording with the exception of the following
changes:High pass filter of 100 Hz and a low pass filter
of 3000 Hz, a click rate of 19/second, averaged 512
sweeps with duration of 10 ms for each average. Record-
ing intensity schedules were performed as described
above for AC recording.As previously explained, the
transducer was placed close to the subject’s right ear, and
the electrode placement was channel 1 at the base of the
skull, and the negative and common at the AC. Al-
though atypical for recording ABR, this electrode place-
ment provides far field recordings for the auditory path-
way ipsilateral to the stimulus ear. The positive peaks in
the far field ABR occur around 1.3 (Ⅰ), 2.1 (Ⅱ), 2.9
(III), 3.7 (Ⅳ), and 4.6 (Ⅴ) (Shaw, 1995). The responses
in far field ABR recordings are a complex interaction of
electrical impulses due to dipole orientations of different
structures of the auditory pathway resulting in fast and
slow waves [21]. PeakⅡ has been shown to be closely as-
sociated with the cochlear nucleus in rats [21]. Local field
potentials and electrical vector fields show the latency of
electrical potentials in the IC to be approximately 5.6 ms
and the lateral lemniscus to be approximately 3-3.5 ms.
Although the IC response is approximately at 5.6 ms, sig-
nificant changes in amplitude and latency have been ob-
served in wave Ⅴ, and even wave Ⅳ of some animals,
after ablation of the IC. These results, combined with the
understanding of latency of the lateral lemniscus and IC,
suggest that waves Ⅳ and Ⅴ of the ABR are interac-
tions of the impulses from these structures. For this
study, the data was analyzed as waveⅡ peak to trough am-
plitude as representing the cochlear nucleus and wave V
peak to trough amplitude as representing the response
from the IC.
Salicylate administration:The administration of salic-
ylate was 250 mg/kg intraperitoneal injection mixed with
saline solution in a concentration of 25 mg/ml. AC and
ABR recordings were taken at 2 hours, 1 day, and 3 days
post salicylate and compared to the averaged pretreat-
ment baseline.
Statistical analysis: Our testing hypothesis was for
the presence of amplitude enhancement of auditory
evoked potentials with high intensity stimuli in the brain-
stem response for waveⅡ or waveⅤ representing the co-
chlear nucleus and IC respectively.The data was analyzed
comparing the average responses of all animals at 90 dB
stimuli for each stimulus frequency using a paired t test
with an alpha value of .05.The analysis was performed
with Microsoft Excel 2003 software and graphed as pre
and post treatment line graphs. Examples of input/output
functions are displayed for a qualitative description of da-
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Results
AC recordings: To verify the presence of enhance-
ment of evoked responses at the AC, which were previous-
ly observed in other studies, the amplitude of the peak to
trough P1-N1 was recorded pre and post salicylate treat-
ment (Figure 1A). Figure 1B plots an input/output func-
tion of for one stimulus frequency recording from one an-
imal for all recordings. The input/output data illustrates
the lower amplitude 2 hour post recordings for low inten-
sity stimuli and enhancement with high intensity stimuli.
As expected, the AC amplitude results to 90 dB SPL
stimuli were significantly enhanced at 2 hours post salic-
ylate treatment compared to the pretreatment baseline
(P < 0.05, paired t-test).The enhancement was significant
with all tested stimulus frequencies with the exception of
16 kHz (P = .0685). Figure 1A illustrates a typical wave-
form amplitude enhancement of P1-N1 recorded be-
tween 12 and 35 ms post stimulus.Example of an input/
output function for amplitudes recorded from the AC all
time intervals from one animal in response to 8 kHz tone
bursts was shown in Figure 1B.
Figure 2A displays the comparison of the AC ampli-
tudes of pre and post salicylate at 4, 8, 12, 16 and 20
kHz. It was noted that the overall AC amplitudes aver-
aged across animals did not resolve completely at the 1
day or the 3 day recordings. One animal (092707) has no
data to calculate into the 1 and 3 day averages as it was
necessary for the animal to be euthanized prior to com-
pleting the testing. Figure 2B illustrates the differences
from baseline and enhanced response at 2 hours post treat-
ment (n = 4) compared to the level of resolve at 1 and 3
days after treatment (n = 3).
IC response: In contrast to the AC response enhance-
ments, the waveⅤ amplitude of the ABR was decreased
overall at two hours post salicylate treatment compared
pretreatment baseline averages.
One animal (100107) had extinguished wave Ⅴ re-
sponses for 8 and 20 kHz at 2 hours post salicylate that
resumed at 1 day and 3 day recordings. Three of the
four animals (102607, 092807, and 100107) had missing
responses for 4 kHz stimuli for both pre and 2 hours post
recordings.Consequently, statistical analysis was only ap-
propriate for 12 and 16 kHz stimuli recordings due to the
missing data. Analysis of the two complete data sets re-
sulted in a statistically significant reduction in amplitude
(P < 0.05, paired t-test) for 12 kHz stimuli and a non-sta-
tistically significant reduction of 31% for 16 kHz re-
sponses (P = .0613).Figure 3B plots the data used for sta-
tistical analysis (n = 4). Due to the small amplitudes of
the ABR recordings and large standard deviations, at-
tempts to plot error bars in the negative direction results
in a calculation error due to the first standard deviation
value being below zero micro volts. Further, adding
plots for the 1 and 3 day recordings (n = 3) as in figure
3B results in values much more reduced than the 2 hours
post salicylate values.These problems with the initial
view of the data are explained if the relative amplitudes
for each animal are plotted separately to display the intra
subject variability as in figure 4A.Animal 092707, which
was euthanized prior to recording 1 and 3 days post treat-
ment, has waveⅤ amplitudes grossly larger than the oth-
er three. For this remaining sample, statistical analysis
would provide poor reliability due to its size (n = 3).
Figure 1 (A) Example of a comparison AC waveforms pre and 2
hours post salicylate treatment in response to 90 dB stimuli. (B)
Example of an input/output function for amplitudes recorded from
the AC all time intervals from one animal in response to 8 kHz
tone bursts.
Figure 2 (A) AC amplitudes from 90 dB SPL stimuli averaged for
all animals (n = 4) for averaged pre salicylate baseline compared to
2 hours post treatment. The vertical error bars represent one stan-
dard deviation from the mean displayed in one direction. (B) AC
amplitudes for 90 dB SPL stimuli averaged for all animals (n = 4)
for pre and 2 hours post salicylate displayed with 1 and 3 day record-
ings with partial sample (n = 3).
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However, the qualitative display of the data in figure 9 il-
lustrates a reliable pattern of decrease in overall ampli-
tudes 2 hours post salicylate treatment and resolve to
near baseline values at 1 and 3 days.
Cochlear nucleus response: Similar to wave Ⅴ of
the ABR, wave Ⅱ amplitudes in response to 90 dB SPL
stimuli were overall reduced in amplitude post salicylate
treatment. Responses to 4, 16 and 20 kHz stimuli pre-
sented a statistically significant reduction in amplitude
(P < 0.05, paired t-test) and responses to 8 and 12 kHz
were reduced without reaching the level of statistical sig-
nificance (P = .323; P = .480).
Discussion
The results of the AC amplitude enhancement with 90
dB SPL stimuli post salicylate treatment are consistent
with findings in Yang et al. (2007) who showed a rela-
tionship between these findings and tinnitus-like behav-
iors [13]. Although the findings are similar, Yang et al.’s
data had a statistically significant increase in amplitude
of AC responses for 16 and 20 kHz stimuli.Our observa-
tions resulted in statistically significant increases in AC
responses with 4, 8, 12 and 20 kHz stimuli, and not with
16 kHz. Although not statistically significant, a mean in-
crease in amplitude to 135% of the baseline was present
2 hours post salicylate with 16 kHz. The exact physio-
logical mechanism for the differences in results between
the results in this study and that observed by Yang is un-
certain, but the increased dosage of salicylate from 150
mg/kg used by Yang compared to our dose of 250 mg/kg
is the most likely factor.It was also noted that the ampli-
tudes of the 1 and 3 day AC recordings did not complete-
ly resolve to baseline amplitudes which is also likely to
be dose related. It must also be considered that the 1 and
3 day post treatment data were only based on three of the
four original subjects as previously described.
The results of pre and post salicylate treatment for
waveⅡ andⅤ of the ABR resulted in overall decreases
in amplitude or extinction of the response for some stimu-
lus frequencies. These results suggest that the physiolog-
ical mechanism related to the perception of tinnitus oc-
curs at the AC, or at least superior to the level of the IC.
A noted weakness of this study is poor signal to noise ra-
tio when recording small amplitude ABR responses from
animals while awake using far field electrode record-
ings. However, these results are supported by a recent
study performed by Sun et al. since the completion of da-
ta collection for the present study.Their results confirm
the absence of IC response enhancement with high level
stimuli with locally implanted electrodes [22].Although
the results of these two studies are in agreement, the find-
ings contrast with previously described studies that re-
corded increased spontaneous neural firing rates at the
level of the cochlear nucleus post treatment with cisplat-
in [18] and increased amplitudes for high level stimuli re-
corded locally in the IC post noise exposure or carboplat-
in [14]. These differences in results suggest different physi-
ological mechanisms of auditory system changes related
to tinnitus between salicylate from that of cisplatin, car-
boplatin, or noise exposure pathology.Another limitation
of this current study is a small sampling size.This may al-
so affect the results reaching to a statistic significance.
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